Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A

Journal of Autoimmunity

Volumn 28, Issue 1, 2007, Pages 7-18

  Akatsuka, Toshitaka ^a   Kobayashi, Nobuharu ^a   Ishikawa, Takashi ^b   Saito, Takafumi ^c   Shindo, Michiko ^d   Yamauchi, Masayoshi ^e   Kurokohchi, Kazutaka ^f   Miyazawa, Hitoshi ^a   Duan, Hongying ^a   Matsunaga, Toshiyuki ^a   Komoda, Tsugikazu ^a   Morisseau, Christophe ^g   Hammock, Bruce D ^g  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d Akashi Municipal Hospital   (Japan)

^e Yamauchi Medical Clinic   (Japan)

^f KAGAWA UNIVERSITY   (Japan)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Baculovirus; Hepatitis A virus; Hepatitis C virus; Purification; Radioimmunoassay

Indexed keywords

AN6520 ANTIGEN; ANTIGEN; AUTOANTIBODY; CELL PROTEIN; DRUG METABOLIZING ENZYME; EPOXIDE HYDROLASE; IMMUNOGLOBULIN M; MICROSOME ENZYME; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; GENE LIBRARY; GENE MUTATION; HEPATITIS A; HEPATITIS C; HUMAN; HUMAN CELL; LIVER; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RADIOIMMUNOASSAY; VIRUS PATHOGENESIS;

AUTOANTIBODIES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, COMPLEMENTARY; EPOXIDE HYDROLASES; HEPACIVIRUS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; IMMUNOGLOBULIN M; LIVER NEOPLASMS; MEMBRANES; RADIOIMMUNOASSAY;

EID: 33847067803     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.12.005     Document Type: Article

References (46)

1. Chisari F.V. Unscrambling hepatitis C virus-host interactions. Nature 436 (2005) 930-932
2. Choo Q.-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
3. Shirachi R., Shiraishi H., Tateda A., Kikuchi K., and Ishida N. Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis. Lancet 2 (1978) 853-856
4. Vitvitski L., Trepo C., Prince A.M., and Brotman B. Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet 2 (1979) 1263-1267
5. Tabor E., Mitchell F.D., Goudeau A.M., and Gerety R.J. Detection of an antigen-antibody system in serum associated with human non-A, non-B hepatitis. J Med Virol 4 (1979) 161-169
6. Tohmatsu J., Morimoto T., Katsuhara N., Abe K., and Shikata T. AN6520 Ag: an antigen purified from liver with non-A, non-B Hepatitis. J Med Virol 15 (1985) 357-371
7. Akatsuka T., Tohmatsu J., Yoshihara N., Katsuhara N., Okamoto T., Shikata T., et al. Detection of an antigen (AN6520) possibly related to non-A, non-B hepatitis, by monoclonal antibodies. I. J Med Virol 20 (1986) 33-42
8. Akatsuka T., Tohmatsu J., Abe K., Shikata T., Ishikawa T., Nakajima K., et al. Non-A, non-B hepatitis related AN6520 Ag is a normal cellular protein mainly expressed in liver. II. J Med Virol 20 (1986) 43-56
9. Yamauchi M., Nakajima H., Kimura K., Fujisawa K., Kameda H., Nakahara M., et al. An epidemic of non-A, non-B hepatitis in Japan. Am J Gastroenterol 78 (1983) 652-655
10. Fujisawa K., Yamauchi M., Kameda H., Shikata T., and Nishioka K. Detection of antibodies to hepatitis C virus in patients involved in an outbreak of non-A, non-B hepatitis in the Okitsu area of Japan. In: Hollinger F.B., Lemon S.M., and Margolis H. (Eds). Viral hepatitis and liver disease (1991), Williams and Wilkins, Baltimore 415-417
11. Huh N., and Utakoji T. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Gann 72 (1981) 178-179
12. Lechner J.F., Smoot D.T., Pfeifer A.M.A., Cole K.H., Weston A., Groopman J.D., et al. A non-tumorigenic human liver epithelial cell culture model for chemical and biological carcinogenesis investigations. In: Rhim J.S., and Dritschilo A. (Eds). Neoplastic transformation in human cell systems (1991), Humana Press, New Jersey 307-321
13. McConahey P.J., and Dixon F.J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol 29 (1966) 185-189
14. Nakane P.K., and Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 22 (1974) 1084-1091
15. Mierendorf R.C., Percy C., and Young R.A. Gene isolation by screening λgt11 libraries with antibodies. In: Berger S.L., and Kimmel A.R. (Eds). Guide to molecular cloning techniques (1987), Academic Press, San Diego 458-469
16. Stanley J.R., Tanaka T., Mueller S., Klauskovtun V., and Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 82 (1988) 1864-1870
17. Ekins S., Maenpaa J., and Wrighton A. In vitro metabolism: subcellular fractions. In: Woolf T.F. (Ed). Handbook of drug metabolism (1999), Marcel Dekker, New York 363-399
18. Hinton A.C., and Hammock B.D. Juvenile hormone esterase (JHE) from Tenebrio molitor: full-length cDNA sequence, in vitro expression, and characterization of the recombinant protein. Insect Biochem Molec Biol 33 (2003) 477-487
19. Lacourciere G.M., Vakharia V.N., Tan C.P., Morris D.I., Edwards G.H., Moos M., et al. Interaction of hepatic microsomal epoxide hydrolase derived from a recombinant baculovirus expression system with an azarene oxide and an aziridine substrate analogue. Biochemistry 32 (1993) 2610-2616
20. Maekawa K., Itoda M., Hanioka N., Saito Y., Murayama N., Nakajima O., et al. Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects. Xenobiotica 33 (2003) 277-287
21. Cohen J.I., Ticehurst J.R., Purcell R.H., Buckler-White A., and Baroudy B.M. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 61 (1987) 50-59
22. Shindo M., Di Bisceglie A.M., Biswas R., Mihalik K., and Feinstone S.M. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis 166 (1992) 424-427
23. Jackson M.R., Craft J.A., and Burchell B. Nucleotide and deduced amino acid sequence of human liver microsomal epoxide hydrolase. Nucleic Acids Res 15 (1987) 7188
24. von Dippe P., and Levy D. Reconstitution of the immunopurified 49-kDa sodium-dependent bile acid transport protein derived from hepatocyte sinusoidal plasma membranes. J Biol Chem 265 (1990) 14812-14816
25. Holder J., Yagi H., Dansette P., Jerina D.M., Levin W., Lu A.Y.H., et al. Effects of inducers and epoxide hydrolase on the metabolism of benzo[a]pyrene by liver microsomes and a reconstituted system: analysis by high pressure liquid chromatography. Proc Natl Acad Sci U S A 71 (1974) 4356-4360
26. Ishii Y., Takeda S., Yamada H., and Oguri K. Functional protein-protein interaction of drug metabolizing enzymes. Front Biosci 10 (2005) 887-895
27. Griffin M.J. Regulation of rat liver epoxide hydrolase by tightly bound phosphoinositides. Proc Okla Acad Sci 79 (1999) 1-6
28. De Berardinis V., Moulis C., Maurice M., Beaune P., Pessayre D., Pompon D., et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 58 (2000) 542-551
29. Newman J.W., Morisseau C., and Hammock B.D. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44 (2005) 1-51
30. Gill S.S., Wie S.I., Guenthner T.M., Oesch F., and Hammock B.D. Rapid and sensitive enzyme-linked immunosorbent assay for the microsomal epoxide hydrolase. Carcinogenesis 3 (1982) 1307-1310
31. Zhu Q.S., von Dippe P., Xing W., and Levy D. Membrane topology and cell surface targeting of microsomal epoxide hydrolase. J Biol Chem 274 (1999) 27898-27904
32. von Dippe P., Zhu Q.S., and Levy D. Cell surface expression and bile acid transport function of one topological form of m-epoxide hydrolase. Biochem Biophys Res Commun 309 (2003) 804-809
33. McGlynn K.A., Rosvold E.A., Lustbader E.D., Hu Y., Clapper M.L., Zhou T., et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzyme detoxication of aflatoxin B1. Proc Natl Acad Sci U S A 92 (1995) 2384-2387
34. Sonzogni L., Silvestri L., De Silvestri A., Gritti C., Foti L., Zavaglia C., et al. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Hepatology 36 (2002) 195-201
35. Bogdanos D.P., and Mcfarlane I.G. Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol 39 (2003) 860-863
36. 193-212: a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170 (2003) 1481-1489
37. Kammer A.R., van der Burg S.H., Grabscheid B., Hunziker I.P., Kwappenberg K.M.C., Reichen J., et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 190 (1999) 169-176
38. Yoo B.J., Spaete R.R., Geballe A.P., Selby M., Houghton M., and Han J.H. 5' end-dependent translation initiation of hepatitis-C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region. Virology 191 (1992) 889-899
39. Okita K., and Farber E. An antigen common to preneoplastic hepatocyte populations and to liver cancer induced by N-2-fluorenyl-acetamide, ethionine, or other hepatocarcinogens. Gann Monogr Canc Res 17 (1975) 283-299
40. Levin W., Lu A.Y.H., Thomas P.E., Ryan D., Kizer D.E., and Griffin M.J. Identification of epoxide hydrolase as the preneoplastic antigen in rat liver hyperplastic nodules. Proc Natl Acad Sci U S A 75 (1978) 3240-3243
41. Hammock B.D., Loury D.N., Moody D.E., Ruebner B., Baselt R., Milam K.M., et al. A methodology for the analysis of the preneoplastic antigen. Carcinogenesis 5 (1984) 1467-1473
42. Talcott R.E., Pond S.M., Ketterman A., and Becker C.E. Ethylesterases as indicators of liver damage. I. Studies on malathion carboxylesterases. Toxicol Appl Pharmacol 65 (1982) 69-74
43. Ruoslahti E., and Seppala M. Alpha-fetoprotein in cancer and fetal development. Adv Cancer Res 29 (1979) 275-346
44. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med 11 (2005) 791-796
45. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
46. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102 (2005) 9294-9299